Research and Development Leaders
Life Science Partner excels at recruiting innovative engineers, scientists and senior leaders to drive research and development for break-through advances within biotechnology. From the R&D leader in the new drug development process to the engineer who can orchestrate teams on three continents, Life Science Partner serves its clients with global reach but a highly personalized touch.
Featured Press Release
Life Science Partner announces the recruitment of Richard (Rick) Pellegrino to become Vice President of Advanced Technology Development for K2M.
“Pellegrino is technically sound, an excellent manager, and a scrappy entrepreneurial inventor,” noted Tom Callaway, MD, Founder and President of Life Science Partner. “He is passionate and articulate about platform technologies and their applications.”
Welch Carson has recently acquired K2M, an innovative spinal device company committed to the research, development, and commercialization of solutions for the treatment of spinal pathologies and procedures. In his new role at K2M, Pellegrino will lead a team of engineers for developing new spinal technologies in-house. He will also be working with spine surgeons to build customized products for specific needs.
Pellegrino was the inventor of the core technology of Relievant Medsystems, a company that specializes in developing technology targeting the source of chronic low back pain. In this role, Pellegrino was responsible for all facets of research, product design, engineering, and clinical development and recruited a world-class scientific advisory board. Previously Pellegrino served as Staff Researcher and Development Engineer in three Johnson & Johnson companies; DePuy Spine, Ethicon, and Cordis.
Pellegrino earned a Bachelor of Science degree in Mechanical Engineering Technology from Wentworth Institute of Technology in Boston, Massachusetts. He also earned his associates degree in Applied Science and Mechanical Design from Wentworth Institute of Technology.
K2M was acquired by Stryker.